24/7 Market News Snapshot 19 September, 2025 – Qualigen Therapeutics, Inc. Common Stock (NASDAQ:QLGN)
DENVER, Colo., 19 September, 2025 (www.247marketnews.com) – (NASDAQ:QLGN) are discussed in this article.
Shares of Qualigen Therapeutics, Inc. (QLGN) have experienced a remarkable surge, opening at $3.00 and exhibiting a substantial increase of 122.36%, with current trading levels at $6.315. This impressive uptick has garnered significant market attention, bolstered by a trading volume of 2.64 million shares. Technical indicators suggest the potential for continued upward momentum, with established support and resistance levels indicating promising trading conditions for investors eager to capitalize on this dynamic stock.
In a pivotal development for the company, Qualigen has entered into a strategic investment partnership with Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI), a relationship poised to enhance its capabilities in both biotechnology and cryptocurrency. Under a newly signed securities purchase agreement, Faraday Future will invest approximately $30 million in Qualigen’s common stock as part of a broader PIPE financing initiative amounting to around $41 million. This collaboration aims to synergize electric mobility advancements with Qualigen’s focus on pioneering treatments, fostering innovation within the ever-evolving landscape of cryptocurrency and Web3 technology.
The partnership has attracted considerable interest from distinguished investors, including Binance Labs and Sequoia Capital, allowing Qualigen to explore new financing avenues without diluting current stakeholder investments. Additionally, significant leadership changes are anticipated at Qualigen, with YT Jia assuming the role of Chief Advisor and Jerry Wang stepping in as Co-CEO. This transition is expected to enhance strategic guidance and operational efficiency, enabling Qualigen to execute its vision more effectively.
Kevin Richardson, CEO of Qualigen, articulated the transformative nature of the partnership, emphasizing the commitment to integrating innovative technologies that promise to reshape the future landscape while delivering value to stakeholders and society at large. Both companies are optimistic about leveraging their combined strengths to navigate and enhance the emerging economic ecosystem.
Related news for (QLGN)
- Stocks Taking Flight: Companies Igniting Investor Buzz
- Breaking News: MoBot’s Latest Update as of 07/16/25 08:00 AM
- Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
- Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K